Item 7.01 Regulation FD Disclosure.

On January 9, 2023, Vigil Neuroscience, Inc. (the "Company"), delivered an updated corporate presentation furnished to this report as Exhibit 99.1 as part of the 41st Annual J.P. Morgan Healthcare Conference (the "Conference") in San Francisco. During the course of the Conference, the Company will be conducting meetings with investors.

The information under this Item 7.01, including Exhibit 99.1 hereto, is being furnished herewith and shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall such information be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.

Item 9.01. Financial Statements and Exhibits.




(d) Exhibits

Exhibit
  No.       Description

99.1          Slide Presentation, dated January 9, 2023 (furnished herewith)

104         Cover Page Interactive Data File (embedded within the Inline XBRL document)

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses